Do analysts recommend BWMX or USNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Betterware de Mexico SAPI de C 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor BWMX or USNA?

In the previous week, USANA Health Sciences had 1 more articles in the media than Betterware de Mexico SAPI de C. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Betterware de Mexico SAPI de C. Betterware de Mexico SAPI de C's average media sentiment score of 1.02 beat USANA Health Sciences' score of 0.05 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Betterware de Mexico SAPI de C 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive USANA Health Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer USNA or HNST?

Honest has a consensus target price of $4.84, suggesting a potential downside of 3.78%. Given Honest's stronger consensus rating and higher probable upside, analysts clearly believe Honest is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Honest 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.22

Does the media refer more to USNA or HNST?

In the previous week, USANA Health Sciences had 1 more articles in the media than Honest. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Honest. Honest's average media sentiment score of 1.65 beat USANA Health Sciences' score of 0.05 indicating that Honest is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Honest 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend USNA or PRE?

Prenetics Global has a consensus price target of $35.67, suggesting a potential upside of 74.84%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts clearly believe Prenetics Global is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71

Does the media refer more to USNA or PRE?

In the previous week, USANA Health Sciences had 1 more articles in the media than Prenetics Global. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Prenetics Global. Prenetics Global's average media sentiment score of 1.17 beat USANA Health Sciences' score of 0.05 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Prenetics Global 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend USNA or NAGE?

Niagen Bioscience has a consensus target price of $10.33, suggesting a potential upside of 284.14%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, analysts plainly believe Niagen Bioscience is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Niagen Bioscience 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00

Does the media refer more to USNA or NAGE?

In the previous week, Niagen Bioscience had 4 more articles in the media than USANA Health Sciences. MarketBeat recorded 6 mentions for Niagen Bioscience and 2 mentions for USANA Health Sciences. Niagen Bioscience's average media sentiment score of 0.13 beat USANA Health Sciences' score of 0.05 indicating that Niagen Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Niagen Bioscience 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend USNA or YSG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Yatsen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

USANA Health Sciences (USNA) Competitors

$14.62 -0.21 (-1.42%)

As of 11:30 AM Eastern

Compare

USNA vs. BWMX, HNST, PRE, NAGE, and YSG

Should you buy USANA Health Sciences stock or one of its competitors? USANA Health Sciences's main competitors and comparable companies include Betterware de Mexico SAPI de C (BWMX), Honest (HNST), Prenetics Global (PRE), Niagen Bioscience (NAGE), and Yatsen (YSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Betterware de Mexico SAPI de C (NYSE:BWMX) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Betterware de Mexico SAPI de C has higher earnings, but lower revenue than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Betterware de Mexico SAPI de C	$744M	0.87	$55.37M	$1.83	8.93
USANA Health Sciences	$925.26M	0.30	$10.76M	-$1.21	N/A

In the previous week, USANA Health Sciences had 1 more articles in the media than Betterware de Mexico SAPI de C. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Betterware de Mexico SAPI de C. Betterware de Mexico SAPI de C's average media sentiment score of 1.02 beat USANA Health Sciences' score of 0.05 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Betterware de Mexico SAPI de C	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Betterware de Mexico SAPI de C	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.67
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Betterware de Mexico SAPI de C has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

12.7% of Betterware de Mexico SAPI de C shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Betterware de Mexico SAPI de C has a net margin of 8.35% compared to USANA Health Sciences' net margin of -2.43%. Betterware de Mexico SAPI de C's return on equity of 77.89% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Betterware de Mexico SAPI de C	8.35%	77.89%	11.28%
USANA Health Sciences	-2.43%	3.41%	2.50%

Summary

Betterware de Mexico SAPI de C beats USANA Health Sciences on 11 of the 15 factors compared between the two stocks.

How does USANA Health Sciences compare to Honest?

USANA Health Sciences (NYSE:USNA) and Honest (NASDAQ:HNST) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

In the previous week, USANA Health Sciences had 1 more articles in the media than Honest. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Honest. Honest's average media sentiment score of 1.65 beat USANA Health Sciences' score of 0.05 indicating that Honest is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Honest	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

USANA Health Sciences has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Honest has a beta of 2.32, indicating that its share price is 132% more volatile than the broader market.

USANA Health Sciences has higher revenue and earnings than Honest. Honest is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.30	$10.76M	-$1.21	N/A
Honest	$371.32M	1.49	-$15.69M	-$0.11	N/A

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 45.5% of Honest shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 9.4% of Honest shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

USANA Health Sciences has a net margin of -2.43% compared to Honest's net margin of -3.56%. Honest's return on equity of 4.31% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Honest	-3.56%	4.31%	3.33%

Honest has a consensus target price of $4.84, suggesting a potential downside of 3.78%. Given Honest's stronger consensus rating and higher probable upside, analysts clearly believe Honest is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Honest	2 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.22

Summary

Honest beats USANA Health Sciences on 11 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Prenetics Global?

USANA Health Sciences (NYSE:USNA) and Prenetics Global (NASDAQ:PRE) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Prenetics Global has a consensus price target of $35.67, suggesting a potential upside of 74.84%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts clearly believe Prenetics Global is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

USANA Health Sciences has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market.

USANA Health Sciences has a net margin of -2.43% compared to Prenetics Global's net margin of -47.43%. USANA Health Sciences' return on equity of 3.41% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Prenetics Global	-47.43%	-21.41%	-15.56%

In the previous week, USANA Health Sciences had 1 more articles in the media than Prenetics Global. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Prenetics Global. Prenetics Global's average media sentiment score of 1.17 beat USANA Health Sciences' score of 0.05 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has higher revenue and earnings than Prenetics Global. USANA Health Sciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.30	$10.76M	-$1.21	N/A
Prenetics Global	$154.59M	2.23	-$37.71M	-$4.16	N/A

Summary

USANA Health Sciences beats Prenetics Global on 10 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Niagen Bioscience?

USANA Health Sciences (NYSE:USNA) and Niagen Bioscience (NASDAQ:NAGE) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Niagen Bioscience has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.30	$10.76M	-$1.21	N/A
Niagen Bioscience	$129.42M	1.66	$17.38M	$0.18	14.94

Niagen Bioscience has a net margin of 12.39% compared to USANA Health Sciences' net margin of -2.43%. Niagen Bioscience's return on equity of 17.95% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Niagen Bioscience	12.39%	17.95%	13.17%

Niagen Bioscience has a consensus target price of $10.33, suggesting a potential upside of 284.14%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, analysts plainly believe Niagen Bioscience is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Niagen Bioscience	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Comparatively, 10.0% of Niagen Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Niagen Bioscience had 4 more articles in the media than USANA Health Sciences. MarketBeat recorded 6 mentions for Niagen Bioscience and 2 mentions for USANA Health Sciences. Niagen Bioscience's average media sentiment score of 0.13 beat USANA Health Sciences' score of 0.05 indicating that Niagen Bioscience is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Niagen Bioscience	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

USANA Health Sciences has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market. Comparatively, Niagen Bioscience has a beta of 2.02, suggesting that its share price is 102% more volatile than the broader market.

Summary

Niagen Bioscience beats USANA Health Sciences on 15 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Yatsen?

USANA Health Sciences (NYSE:USNA) and Yatsen (NYSE:YSG) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

USANA Health Sciences has higher revenue and earnings than Yatsen. USANA Health Sciences is trading at a lower price-to-earnings ratio than Yatsen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.30	$10.76M	-$1.21	N/A
Yatsen	$614.62M	0.39	-$11.56M	-$0.32	N/A

USANA Health Sciences has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Yatsen has a beta of -1.71, suggesting that its stock price is 271% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Yatsen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

54.3% of USANA Health Sciences shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Comparatively, 29.0% of Yatsen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

USANA Health Sciences has a net margin of -2.43% compared to Yatsen's net margin of -4.63%. USANA Health Sciences' return on equity of 3.41% beat Yatsen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Yatsen	-4.63%	-7.26%	-5.42%

In the previous week, USANA Health Sciences had 2 more articles in the media than Yatsen. MarketBeat recorded 2 mentions for USANA Health Sciences and 0 mentions for Yatsen. USANA Health Sciences' average media sentiment score of 0.05 beat Yatsen's score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
USANA Health Sciences	Neutral
Yatsen	Neutral

Summary

USANA Health Sciences beats Yatsen on 9 of the 13 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USNA vs. The Competition

Export

Metric	USANA Health Sciences	Personal Care Products Industry	Consumer Staples Sector	NYSE Exchange
Market Cap	$270.27M	$22.76B	$15.54B	$22.76B
Dividend Yield	N/A	5.53%	3.34%	3.72%
P/E Ratio	-12.09	21.10	13.76	27.77
Price / Sales	0.29	12.59	264,296.73	14.48
Price / Cash	3.60	26.36	57.00	36.95
Price / Book	0.50	2.83	4.28	4.66
Net Income	$10.76M	$1.13B	$839.81M	$1.07B
7 Day Performance	0.90%	-0.82%	-0.39%	0.10%
1 Month Performance	-1.75%	-7.49%	-4.74%	-6.10%
1 Year Performance	-44.54%	-22.67%	7.92%	5.40%

USANA Health Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USNA USANA Health Sciences	1.5378 of 5 stars	$14.62 -1.4%	N/A	-44.0%	$270.27M	$925.26M	N/A	1,570	News Coverage Analyst Upgrade
BWMX Betterware de Mexico SAPI de C	4.677 of 5 stars	$16.96 +1.3%	N/A	+27.4%	$660.98M	$744M	9.27	2,441	Positive News
HNST Honest	2.4879 of 5 stars	$5.30 +0.2%	$4.84 -8.7%	+26.7%	$582.32M	$371.32M	N/A	174	Positive News
PRE Prenetics Global	4.5637 of 5 stars	$22.76 -0.9%	$35.67 +56.7%	+36.2%	$387.60M	$92.39M	N/A	98	Positive News Gap Up
NAGE Niagen Bioscience	2.6736 of 5 stars	$2.98 -2.3%	$10.33 +246.8%	-62.9%	$242.91M	$129.42M	16.56	117

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:USNA) was last updated on 10/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USANA Health Sciences (USNA) Competitors

USNA vs. BWMX, HNST, PRE, NAGE, and YSG

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Summary

How does USANA Health Sciences compare to Honest?

Summary

How does USANA Health Sciences compare to Prenetics Global?

Summary

How does USANA Health Sciences compare to Niagen Bioscience?

Summary

How does USANA Health Sciences compare to Yatsen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USANA Health Sciences (USNA) Competitors

USNA vs. BWMX, HNST, PRE, NAGE, and YSG

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Which has stronger valuation and earnings, BWMX or USNA?

Does the media favor BWMX or USNA?

Do analysts recommend BWMX or USNA?

Which has more volatility and risk, BWMX or USNA?

Do institutionals and insiders hold more shares of BWMX or USNA?

Is BWMX or USNA more profitable?

Summary

How does USANA Health Sciences compare to Honest?

Does the media refer more to USNA or HNST?

Which has more risk and volatility, USNA or HNST?

Which has higher valuation and earnings, USNA or HNST?

Do insiders and institutionals hold more shares of USNA or HNST?

Is USNA or HNST more profitable?

Do analysts prefer USNA or HNST?

Summary

How does USANA Health Sciences compare to Prenetics Global?

Do insiders & institutionals hold more shares of USNA or PRE?

Do analysts recommend USNA or PRE?

Which has more volatility & risk, USNA or PRE?

Is USNA or PRE more profitable?

Does the media refer more to USNA or PRE?

Which has higher valuation & earnings, USNA or PRE?

Summary

How does USANA Health Sciences compare to Niagen Bioscience?

Which has preferable valuation and earnings, USNA or NAGE?

Is USNA or NAGE more profitable?

Do analysts recommend USNA or NAGE?

Do institutionals and insiders hold more shares of USNA or NAGE?

Does the media refer more to USNA or NAGE?

Which has more volatility and risk, USNA or NAGE?

Summary

How does USANA Health Sciences compare to Yatsen?

Which has stronger earnings & valuation, USNA or YSG?

Which has more risk & volatility, USNA or YSG?

Do analysts recommend USNA or YSG?

Do institutionals & insiders hold more shares of USNA or YSG?

Is USNA or YSG more profitable?

Does the media refer more to USNA or YSG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools